Qiong Wu

AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations

Shun Lü, Xiaorong Dong, Hong Jian et al. · Journal of Clinical Oncology · 2022 · 279 citations · Full text

Medicine, Oncology, Pharmacology +16

Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial

Shun Lü, Qiming Wang, Guojun Zhang et al. · Journal of Thoracic Oncology · 2021 · 143 citations · Full text

Medicine, Oncology, Pharmacology +11

A Selective Small Molecule DNA2 Inhibitor for Sensitization of Human Cancer Cells to Chemotherapy

Wenpeng Liu, Mian Zhou, Zhengke Li et al. · EBioMedicine · 2016 · 100 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer

Jingjing Zhang, Qiong Wu, Lucheng Zhu et al. · Cancer Letters · 2021 · 93 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Label-free liquid biopsy based on blood circulating DNA detection using SERS-based nanotechnology for nasopharyngeal cancer screening

Duo Lin, Qiong Wu, Sufang Qiu et al. · Nanomedicine Nanotechnology Biology and Medicine · 2019 · 55 citations

Medicine, Bioengineering, Biomedical Engineering +17